Minsk Prefecture attaches importance to the development of traditional Chinese medicine industry in Zhongbai Industrial Park

发布于: 2021-09-23 00:00

Zhongbai Industrial Park September 23

On September 22, Turchin Alexander, chairman of Minsk regional Executive Committee, met with CAI Chuanqing, President of Jintai Academy of culture.

 

 

At the symposium, Turchin said that China is a strategic partner of Belarus and Minsk state, and the China Belarus Industrial Park is located in Minsk state, which will deepen the mode of cooperation between Belarus and China. At present, the Belarusian government is having an active dialogue with President Cai Chuanqing on the establishment of a sub Park of traditional Chinese medicine in the park and has reached an agreement.

 

President Cai Chuanqing expressed his gratitude to the Belarusian government for its support for the development of traditional Chinese medicine in the park. He hoped that in the future, traditional Chinese medicine could be planted and produced not only in the park, but also in the whole of Belarus. At the same time, he would also vigorously promote large Chinese pharmaceutical enterprises to invest and develop in the park.

 

After the talks, the two sides signed a memorandum of cooperation.

 

 

During the talks, President Cai Chuanqing also introduced to President Tulchin the Qing Qing soft capsule, which was planned to produce in the park. The capsule has proved the effectiveness of the treatment for COVID-19 in the practice of epidemic prevention in Ukraine, Russia and other countries.

 

Karojev, the first deputy general manager of the park development company, attended the above meeting.

 

Share

Recommended articles

  • 2021-11-11
      The world's first proprietary Chinese medicine for the treatment of COVID-19 has been released   Zhou Xingting   Yao jian   "Linglan Pesticide-clear" is developed and produced by New Times Biotechnology Co., LTD., a Traditional Chinese medicine enterprise in China-Belarus Industrial Park.     The world's first effective Chinese patent medicine for COVID-19 treatment   Southern Guangdong introduced "linglan epidemic qing" registered sales in Australia    On November 5, on the occasion of the opening of the China International Import Expo, the press conference on Traditional Chinese medicine products of the China-Belarus Industrial Park and the signing ceremony of the cooperation agreement of the China-Belarus Industrial Park jointly hosted by the Belarusian Embassy in China, chin...
  • 2021-11-10
      On January 5, Qingfu Capsule, the world's first pure herbal medicine for COVID-19, was jointly developed by China and Belarus and launched in Shanghai. The drug will be produced in the China-Belarus Industrial Park on the outskirts of Minsk, Belarus.   China-belarus Industrial Park Chinese medicine enterprise new era biological medicine company qingfu capsule launch ceremony     Qingfu Capsule is a pure natural plant extract capsule developed and produced by Dr. CAI Chuanqing of Jintai Cultural Institute of China using modern technology combined with traditional medical essence, which can effectively treat and prevent COVID-19. Since February 2020, Linglan granules have successfully cured COVID-19 patients in many countries, including former Ukrainian Prime Minister Yulia Tymoshenko and president Petro Poros...
  • 2021-11-10
      On November 5, when the China International Import Expo opened, the China-Belarus Industrial Park held a press conference on Traditional Chinese medicine products of the Industrial Park and the signing ceremony of the cooperation agreement between the industrial park, demonstrating the major achievements of china-Belarus anti-epidemic cooperation.     According to reports, qingfu capsule series, originated from the classic formula in Treatises on Typhoid fever 1800 years ago, combined with the successful experience of Traditional Chinese medicine in fighting malignant infectious diseases such as The Outbreak of Blast, combined with modern medicine, in view of novel coronavirus characteristics of rapid transmission, rapid disease progression, high mortality and many sequelae, is a new formula. Novel Coronavirus can effectively inhibit novel Coronavirus, redu...